• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠患者中的高密度脂蛋白:来自一项意大利横断面研究的证据。

HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study.

作者信息

Papotti Bianca, Macchi Chiara, Favero Chiara, Iodice Simona, Adorni Maria Pia, Zimetti Francesca, Corsini Alberto, Aliberti Stefano, Blasi Francesco, Carugo Stefano, Bollati Valentina, Vicenzi Marco, Ruscica Massimiliano

机构信息

Department of Food and Drug, University of Parma, 43124 Parma, Italy.

Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20100 Milan, Italy.

出版信息

J Clin Med. 2021 Dec 18;10(24):5955. doi: 10.3390/jcm10245955.

DOI:10.3390/jcm10245955
PMID:34945250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8708284/
Abstract

A number of studies have highlighted important alterations of the lipid profile in COVID-19 patients. Besides the well-known atheroprotective function, HDL displays anti-inflammatory, anti-oxidative, and anti-infectious properties. The aim of this retrospective study was to assess the HDL anti-inflammatory and antioxidant features, by evaluation of HDL-associated Serum amyloid A (SAA) enrichment and HDL-paraoxonase 1 (PON-1) activity, in a cohort of COVID-19 patients hospitalized at the Cardiorespiratory COVID-19 Unit of Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan. COVID-19 patients reached very low levels of HDL-c (mean ± SD: 27.1 ± 9.7 mg/dL) with a marked rise in TG (mean ± SD: 165.9 ± 62.5 mg/dL). Compared to matched-controls, SAA levels were significantly raised in COVID-19 patients at admission. There were no significant differences in the SAA amount between 83 alive and 22 dead patients for all-cause in-hospital mortality. Similar findings were reached in the case of PON-1 activity, with no differences between alive and dead patients for all-cause in-hospital mortality. In conclusion, although not related to the prediction of in-hospital mortality, reduction in HDL-c and the enrichment of SAA in HDL are a mirror of SARS-CoV-2 positivity even at the very early stages of the infection.

摘要

多项研究强调了新冠病毒肺炎(COVID-19)患者血脂谱的重要改变。除了众所周知的抗动脉粥样硬化保护功能外,高密度脂蛋白(HDL)还具有抗炎、抗氧化和抗感染特性。本回顾性研究的目的是,通过评估HDL相关血清淀粉样蛋白A(SAA)富集情况和HDL对氧磷酶1(PON-1)活性,来评估一组在米兰 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico医院心肺COVID-19科室住院的COVID-19患者中HDL的抗炎和抗氧化特征。COVID-19患者的HDL-c水平极低(平均值±标准差:27.1±9.7mg/dL),甘油三酯(TG)显著升高(平均值±标准差:165.9±62.5mg/dL)。与匹配的对照组相比,COVID-19患者入院时SAA水平显著升高。在83名存活患者和22名因各种原因院内死亡的患者之间,SAA量没有显著差异。PON-1活性情况也有类似发现,存活患者和死亡患者在各种原因院内死亡率方面没有差异。总之,虽然与院内死亡率的预测无关,但HDL-c降低和HDL中SAA富集是SARS-CoV-2阳性的反映,即使在感染的极早期阶段也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad09/8708284/aab40411b488/jcm-10-05955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad09/8708284/aab40411b488/jcm-10-05955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad09/8708284/aab40411b488/jcm-10-05955-g001.jpg

相似文献

1
HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study.新冠患者中的高密度脂蛋白:来自一项意大利横断面研究的证据。
J Clin Med. 2021 Dec 18;10(24):5955. doi: 10.3390/jcm10245955.
2
Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.结节病患者血清淀粉样蛋白A和氧化应激与对氧磷酶1的关联。
Eur J Clin Invest. 2016 May;46(5):418-24. doi: 10.1111/eci.12610. Epub 2016 Mar 17.
3
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
4
Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.血清对氧磷酶-1 活性降低与代谢综合征患者血清淀粉样蛋白 A 水平升高有关。
Arch Med Res. 2011 Apr;42(3):219-25. doi: 10.1016/j.arcmed.2011.05.002.
5
Subclinical myopathic changes in COVID-19.COVID-19 中的亚临床肌病变化。
Neurol Sci. 2021 Oct;42(10):3973-3979. doi: 10.1007/s10072-021-05469-8. Epub 2021 Jul 25.
6
Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study.住院成年患者感染新冠病毒12个月后患者报告的症状及后遗症:一项多中心长期随访研究
Front Med (Lausanne). 2022 Mar 22;9:834354. doi: 10.3389/fmed.2022.834354. eCollection 2022.
7
Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number.心房颤动与高密度脂蛋白功能、代谢和颗粒数的改变有关。
Basic Res Cardiol. 2019 May 8;114(4):27. doi: 10.1007/s00395-019-0735-0.
8
Metabolic Changes in SARS-CoV-2 Infection: Clinical Data and Molecular Hypothesis to Explain Alterations of Lipid Profile and Thyroid Function Observed in COVID-19 Patients.新型冠状病毒感染中的代谢变化:解释新冠肺炎患者脂质谱和甲状腺功能改变的临床数据及分子假说
Life (Basel). 2021 Aug 22;11(8):860. doi: 10.3390/life11080860.
9
The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation.HDL 的抗炎功能在 2 型糖尿病中受损:高血糖、对氧磷酶-1 和低度炎症的作用。
Cardiovasc Diabetol. 2017 Oct 12;16(1):132. doi: 10.1186/s12933-017-0613-8.
10
Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.肿瘤坏死因子阻断后高密度脂蛋白组成发生抗动脉粥样硬化改变,同时血脂谱得到改善:一项强直性脊柱炎的前瞻性队列研究
Arthritis Rheum. 2009 May;60(5):1324-30. doi: 10.1002/art.24492.

引用本文的文献

1
High-density lipoproteins and COVID-19: preparing the next pandemic.高密度脂蛋白与2019冠状病毒病:为下一场大流行做准备
J Lipid Res. 2025 May;66(5):100779. doi: 10.1016/j.jlr.2025.100779. Epub 2025 Mar 14.
2
Association between lipid profile and clinical outcomes in COVID-19 patients.新冠肺炎患者血脂谱与临床结局的相关性。
Sci Rep. 2024 May 27;14(1):12139. doi: 10.1038/s41598-024-62899-y.
3
Improvements during long-term fasting in patients with long COVID - a case series and literature review.长期新冠患者长期禁食期间的改善——病例系列及文献综述

本文引用的文献

1
HDL proteome remodeling associates with COVID-19 severity.高密度脂蛋白蛋白质组重塑与 COVID-19 严重程度相关。
J Clin Lipidol. 2021 Nov-Dec;15(6):796-804. doi: 10.1016/j.jacl.2021.10.005. Epub 2021 Oct 31.
2
High-density lipoprotein cholesterol: A marker of COVID-19 infection severity?高密度脂蛋白胆固醇:新冠病毒感染严重程度的一个标志物?
Atheroscler Plus. 2021 Oct;44:1-9. doi: 10.1016/j.athplu.2021.08.007. Epub 2021 Aug 24.
3
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19.
Front Nutr. 2023 Nov 2;10:1195270. doi: 10.3389/fnut.2023.1195270. eCollection 2023.
4
Angiotensin Converting Enzyme 1 Polymorphisms and Lipid Profile in Mexican Patients With COVID-19.血管紧张素转换酶 1 多态性与 COVID-19 墨西哥患者的脂质谱。
In Vivo. 2023 Jan-Feb;37(1):433-439. doi: 10.21873/invivo.13096.
5
Dyslipidemia and Inflammation as Hallmarks of Oxidative Stress in COVID-19: A Follow-Up Study.脂代谢紊乱和炎症是 COVID-19 氧化应激的特征:一项随访研究。
Int J Mol Sci. 2022 Dec 5;23(23):15350. doi: 10.3390/ijms232315350.
6
Paraoxonase 1 rs662 polymorphism, its related variables, and COVID-19 intensity: Considering gender and post-COVID complications.对氧磷酶 1 rs662 多态性、相关变量与 COVID-19 严重程度:考虑性别和新冠病毒感染后并发症。
Exp Biol Med (Maywood). 2023 Dec;248(23):2351-2362. doi: 10.1177/15353702221128563. Epub 2022 Oct 31.
7
Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19.血清对氧磷酶 1 芳基酯酶活性测定在 COVID-19 诊断中的应用。
Biomolecules. 2022 Jun 23;12(7):879. doi: 10.3390/biom12070879.
8
The Role of High-Density Lipoprotein Cholesterol in 2022.2022 年高密度脂蛋白胆固醇的作用。
Curr Atheroscler Rep. 2022 May;24(5):365-377. doi: 10.1007/s11883-022-01012-y. Epub 2022 Mar 10.
住院期间的高甘油三酯血症与 COVID-19 患者的死亡率独立相关。
J Clin Lipidol. 2021 Sep-Oct;15(5):724-731. doi: 10.1016/j.jacl.2021.08.002. Epub 2021 Aug 10.
4
Distinct lipid metabolic dysregulation in asymptomatic COVID-19.无症状新冠肺炎患者存在独特的脂质代谢失调。
iScience. 2021 Sep 24;24(9):102974. doi: 10.1016/j.isci.2021.102974. Epub 2021 Aug 11.
5
The Role of High-Density Lipoprotein in COVID-19.高密度脂蛋白在2019冠状病毒病中的作用
Front Pharmacol. 2021 Jul 16;12:720283. doi: 10.3389/fphar.2021.720283. eCollection 2021.
6
Association between serum amyloid A levels and predicting disase severity in COVID-19 patients: a systematic review and meta-analysis.血清淀粉样蛋白 A 水平与 COVID-19 患者疾病严重程度预测的相关性:系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4627-4638. doi: 10.26355/eurrev_202107_26255.
7
Effects of fatty acids on T cell function: role in atherosclerosis.脂肪酸对 T 细胞功能的影响:在动脉粥样硬化中的作用。
Nat Rev Cardiol. 2021 Dec;18(12):824-837. doi: 10.1038/s41569-021-00582-9. Epub 2021 Jul 12.
8
Clinical Performance of Paraoxonase-1-Related Variables and Novel Markers of Inflammation in Coronavirus Disease-19. A Machine Learning Approach.对氧磷酶-1相关变量及新型炎症标志物在冠状病毒病-19中的临床性能。一种机器学习方法。
Antioxidants (Basel). 2021 Jun 21;10(6):991. doi: 10.3390/antiox10060991.
9
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.COVID-19 患者住院死亡率的预后参数:意大利经验。
Eur J Clin Invest. 2021 Sep;51(9):e13629. doi: 10.1111/eci.13629. Epub 2021 Jun 29.
10
Changing Perspectives on HDL: From Simple Quantity Measurements to Functional Quality Assessment.对高密度脂蛋白(HDL)的认知转变:从单纯的量度测量到功能质量评估。
J Lipids. 2021 Apr 26;2021:5585521. doi: 10.1155/2021/5585521. eCollection 2021.